AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

Two plant compounds with potential as GLP-1 agonist weight loss pills have been identified in an AI (artificial intelligence)-based study, the European Congress on Obesity (ECO 2024) (Venice 12-15 May), will hear.

MBrace Therapeutics capitalizes on ADC wave with $85M Series B to enter the clinic this quarter

MBrace Therapeutics has raised an $85 million Series B for a Phase I clinical trial of its first antibody-drug conjugate as investors and Big Pharmas

November 15, 2023

Meet the fetal surgeon forging CRISPR’s next frontier: curing diseases in the womb

SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of fog blanketing the San Francisco skyline. Its warmth did not

February 21, 2024

Cardiovascular health disparities persist in puzzling ways, studies find

Last week’s election results may signal political winds sweeping attention away from diversity, equity, and inclusion, but new research papers again make the case that people

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.